Public Health - Medetomidine and Xylazine Consumer Protection Act
Sponsor: Jesse T. Pippy (District 4)Committee: Health and Government OperationsSubject: Public HealthStatus: Hearing 3/05 at 2:40 p.m. (as of Dec 1, 2025)
What this bill does
Official synopsis
Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or a xylazine product unless the purchaser provides to the retailer certain proof; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or a xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine product or a xylazine product to maintain certain records; etc.
AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (0)
MGA witness listFAV 3FavorableFWA 1Favorable with amendments
| Position | Witness | Organization | Testimony |
|---|---|---|---|
| FAV | Delegate Pippy, Delegate Pippylegislator | Individual | Oral |
| FAV | Meyerovich, Mark | Individual | Position only |
| FAV | Tibbals, Trudy | Individual | Position only |
| FWA | Williams, Irnise | OAG | Written (PDF) |
Organizations on record
OAGFWA 1